US2008146530A1PendingUtilityA1
Re-epithelializing pharmaceutical compositions comprising xanthan gum
Est. expiryApr 30, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/04A61P 29/00A61P 27/02A61P 31/00A61K 31/573A61K 9/06A61K 31/7036A61K 47/36A61K 31/715A61K 31/661A61K 31/723A61K 9/0048A61P 17/00A61P 17/02A61K 31/728
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of xanthan gum as re-epithelializing agent and, in particular, to a pharmaceutical formulation comprising xanthan gum as a re-epithelializing active principle eventually mixed with hyaluronic acid. Said use and composition speed up and improve advantageously the formation of newly grown epithelium.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled)
20 . Pharmaceutical composition consisting of:
Dexamethasone disodium phosphate
0.1500 g
Active principle
Netilmicin sulfate
0.4550 g
Active principle
equivalent to
Netilmicin base
0.3000 g
Xanthan gum
1.0000 g
Active principle,
re-epithelializing
Sodium phosphate dibasic•12H 2 O
0.5000 g
Buffer
Sodium phosphate monobasic•H 2 O
0.1465 g
Buffer
Sodium citrate•2H 2 O
2.1000 g
Antioxidant
Purified water q.s. to
100.0 ml
Solvent
21 - 23 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.